National Center for Tumor Diseases (NCT) Heidelberg
Martin Niklas serves as a Clinician Scientist at DKFZ Deutsches Krebsforschungszentrum since 2010, focusing on tumor diagnostics and clinical studies, and coordinates the multi-center study PUMA. Previously, Martin was a project leader, developing biosensors and functionalized nanoparticles for molecular diagnostics and personalized cancer therapy, as well as image processing algorithms. Martin's academic background includes a medical degree from Heidelberg University, a PhD in Physics from the same institution, and a Diplom in Physics with a supplementary certification in Biophysics from several prestigious universities. Earlier in Martin's career, experience as an IT specialist at Siemens AG involved software engineering and the establishment of IT infrastructure in heavy industry.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.